# Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers

> **NCT00969553** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 59 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BI 6727

## Key facts

- **NCT ID:** NCT00969553
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2019-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969553, "Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00969553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*